We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.
- Authors
Riffel, Philipp; Schwaab, Juliana; Lutz, Christopher; Naumann, Nicole; Metzgeroth, Georgia; Fabarius, Alice; Schoenberg, Stefan O.; Hofmann, Wolf-Karsten; Valent, Peter; Reiter, Andreas; Jawhar, Mohamad
- Abstract
Purpose: Systemic mastocytosis (SM) is characterized by the expansion of clonal mast cells that infiltrate various organ systems. The extent of organ infiltration and subsequent organ damage distinguishes between indolent SM (ISM) defined by a nearly normal life expectancy and advanced SM (AdvSM) defined by poor prognosis. In ISM, measurement of the bone mineral density (BMD) frequently reveals osteoporosis. In contrast, the clinical implication of an increased BMD and osteosclerosis remains unclear. Methods: BMD was evaluated in 61 patients with mastocytosis (ISM, n = 29, 48%; AdvSM, n = 32, 52%). We correlated the prevalence of osteoporosis, increased BMD and osteosclerosis with clinical parameters, disease variant and prognosis. Results: Osteoporosis was detected in 11/29 (38%) patients with ISM but only in 2/32 (6%) patients with AdvSM (p = 0.004). An increased BMD was detected in 1/29 (3%) patients with ISM and 24/32 (75%) patients with AdvSM (p < 0.001) while osteosclerosis was only detected in AdvSM patients (16/32, 50%). AdvSM patients with increased BMD had higher levels of bone marrow mast cell infiltration, higher serum tryptase and alkaline phosphatase levels compared to ISM as well as higher number of high-molecular risk mutations (p < 0.05). In addition, we found that the prognosis of AdvSM patients with increased BMD is inferior compared to those without increased BMD (median overall survival 3.6 years versus not reached, p = 0.031). Conclusions: Osteoporosis is a common feature in ISM but not in AdvSM. An increased BMD is frequently present in AdvSM but not in ISM and is associated with more advanced disease and inferior outcome.
- Subjects
BONE density; MAST cell disease; BONE densitometry; BONE marrow cells; CLONE cells; ALKALINE phosphatase
- Publication
Journal of Cancer Research & Clinical Oncology, 2020, Vol 146, Issue 4, p945
- ISSN
0171-5216
- Publication type
Article
- DOI
10.1007/s00432-019-03119-3